Keene & Associates, Inc. Avanos Medical, Inc. Transaction History
Keene & Associates, Inc.
- $121 Million
- Q2 2024
A detailed history of Keene & Associates, Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Keene & Associates, Inc. holds 18,635 shares of AVNS stock, worth $447,053. This represents 0.31% of its overall portfolio holdings.
Number of Shares
18,635
Previous 16,050
16.11%
Holding current value
$447,053
Previous $319,000
16.3%
% of portfolio
0.31%
Previous 0.24%
Shares
10 transactions
Others Institutions Holding AVNS
# of Institutions
272Shares Held
42.1MCall Options Held
800Put Options Held
9.2K-
Black Rock Inc. New York, NY7.01MShares$168 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.27MShares$126 Million0.0% of portfolio
-
Rgm Capital, LLC Naples, FL3.17MShares$76.1 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.58MShares$61.8 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.22MShares$53.2 Million0.03% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $1.12B
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...